QuickLinks -- Click here to rapidly navigate through this documentStrategic Alliance Agreement • September 29th, 2004 • Theravance Inc • Pharmaceutical preparations • Delaware
[*]=CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.
COLLABORATION AGREEMENT by and between THERAVANCE, INC. and GLAXO GROUP LIMITED Dated: November 14, 2002Preferred Stock Purchase Agreement • September 29th, 2004 • Theravance Inc • Pharmaceutical preparations • Delaware
This COLLABORATION AGREEMENT ("Agreement") dated November 14, 2002, is made by and between THERAVANCE, INC., a Delaware corporation, and having its principal office at 901 Gateway Boulevard, South San Francisco, California 94080 ("Theravance"), and GLAXO GROUP LIMITED, a United Kingdom corporation, and having its principal office at Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 0NN, United Kingdom ("GSK"). Theravance and GSK may be referred to as a "Party" or together, the "Parties".
THERAVANCE, INC. CLASS A COMMON STOCK PURCHASE AGREEMENT September , 2004Common Stock Purchase Agreement • September 29th, 2004 • Theravance Inc • Pharmaceutical preparations • Delaware
QuickLinks -- Click here to rapidly navigate through this documentTheravance Inc • September 29th, 2004 • Pharmaceutical preparations
[*]=CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.
